The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle

Biomaterials

Volumn 32, Issue 14, 2011, Pages 3575-3583

  Hinds, Sara ^a   Bian, Weining ^a   Dennis, Robert G ^b   Bursac, Nenad ^a  

^a Duke University   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Contractile force; Hydrogel; Myogenesis; Skeletal myoblasts

Indexed keywords

ACTIVE FORCE GENERATION; CELL MATRIX INTERACTIONS; CLINICAL UTILITY; COLLAGEN I; CONTRACTILE FORCE; EXTRACELLULAR MATRICES; FORCE GENERATION; FORCE-LENGTH; GROWTH FACTOR; HALF-WIDTH; IN-CONTROL; INTRACELLULAR CA; MATRIX COMPOSITION; MATRIX PROTEINS; MUSCLE TISSUES; MYOFIBERS; MYOGENESIS; NEONATAL RAT; SKELETAL MUSCLE; SKELETAL MYOBLASTS; TISSUE STRUCTURE; UNDERLYING CAUSE;

BIOLOGICAL MATERIALS; BIOMECHANICS; CALCIUM; CELL CULTURE; COLLAGEN; ENZYME ACTIVITY; HYDROGELS; MECHANICAL PROPERTIES;

MUSCLE;

CALCIUM; CELL PROTEIN; COLLAGEN TYPE 1; DNA; FIBRIN; MATRIGEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CALCIUM CELL LEVEL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HYDROGEL; IMMUNOHISTOCHEMISTRY; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE TETANIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TISSUE CULTURE; TISSUE STRUCTURE;

ANIMALS; BIOENGINEERING; CALCIUM; CELLS, CULTURED; EXTRACELLULAR MATRIX; HYDROGELS; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 79952100021     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.01.062     Document Type: Article

References (47)

1. Alsberg E., Hill E.E., Mooney D.J. Craniofacial tissue engineering. Crit Rev Oral Biol Med 2001, 12:64-75.
2. Bach A.D., Beier J.P., Stern-Staeter J., Horch R.E. Skeletal muscle tissue engineering. J Cell Mol Med 2004, 8:413-422.
3. Vilquin J.T. Myoblast transplantation: clinical trials and perspectives. Mini-review. Acta Myol 2005, 24:119-127.
4. Bian W., Bursac N. Tissue engineering of functional skeletal muscle: challenges and recent advances. IEEE Eng Med Biol Mag 2008, 27:109-113.
5. Liao H., Zhou G.Q. Development and progress of engineering of skeletal muscle tissue. Tissue Eng Part B Rev 2009, 15:319-331.
6. Velleman S.G. The role of the extracellular matrix in skeletal muscle development. Poult Sci 1999, 78:778-784.
7. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 2004, 84:649-698.
8. Osses N., Brandan E. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am J Physiol Cell Physiol 2002, 282:C383-C394.
9. Stern M.M., Myers R.L., Hammam N., Stern K.A., Eberli D., Kritchevsky S.B., et al. The influence of extracellular matrix derived from skeletal muscle tissue on the proliferation and differentiation of myogenic progenitor cells ex vivo. Biomaterials 2009, 30:2393-2399.
10. DeQuach J.A., Mezzano V., Miglani A., Lange S., Keller G.M., Sheikh F., et al. Simple and high yielding method for preparing tissue specific extracellular matrix coatings for cell culture. PloS One 2010, 5:e13039.
11. Okano T., Satoh S., Oka T., Matsuda T. Tissue engineering of skeletal muscle. Highly dense, highly oriented hybrid muscular tissues biomimicking native tissues. Asaio J 1997, 43:M749-M753.
12. Bian W., Bursac N. Engineered skeletal muscle tissue networks with controllable architecture. Biomaterials 2009, 30:1401-1412.
13. Yan W., George S., Fotadar U., Tyhovych N., Kamer A., Yost M.J., et al. Tissue engineering of skeletal muscle. Tissue Eng 2007, 13:2781-2790.
14. Rhim C., Lowell D.A., Reedy M.C., Slentz D.H., Zhang S.J., Kraus W.E., et al. Morphology and ultrastructure of differentiating three-dimensional mammalian skeletal muscle in a collagen gel. Muscle Nerve 2007, 36:71-80.
15. Yamamoto Y., Ito A., Fujita H., Nagamori E., Kawabe Y., Kamihira M. Functional evaluation of artificial skeletal muscle tissue constructs fabricated by a magnetic force-based tissue engineering technique. Tissue Eng Part A 2011, 17:107-114.
16. Huang Y.C., Dennis R.G., Larkin L., Baar K. Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol 2005, 98:706-713.
17. Vandenburgh H., Shansky J., Benesch-Lee F., Barbata V., Reid J., Thorrez L., et al. Drug-screening platform based on the contractility of tissue-engineered muscle. Muscle Nerve 2008, 37:438-447.
18. Lam M.T., Huang Y.C., Birla R.K., Takayama S. Microfeature guided skeletal muscle tissue engineering for highly organized 3-dimensional free-standing constructs. Biomaterials 2009, 30:1150-1155.
19. Rhim C., Cheng C.S., Kraus W.E., Truskey G.A. Effect of microRNA modulation on bioartificial muscle function. Tissue Eng Part A 2010, 16:3589-3597.
20. Frueh B.R., Gregorevic P., Williams D.A., Lynch G.S. Specific force of the rat extraocular muscles, levator and superior rectus, measured in situ. J Neurophysiology 2001, 85:1027-1032.
21. Monti R.J., Roy R.R., Hodgson J.A., Edgerton V.R. Transmission of forces within mammalian skeletal muscles. J Biomech 1999, 32:371-380.
22. Patel T.J., Lieber R.L. Force transmission in skeletal muscle: from actomyosin to external tendons. Exerc Sport Sciences Reviews 1997, 25:321-363.
23. Young M., Paul A., Rodda J., Duxson M., Sheard P. Examination of intrafascicular muscle fiber terminations: implications for tension delivery in series-fibered muscles. J Morphology 2000, 245:130-145.
24. Paul A.C., Sheard P.W., Kaufman S.J., Duxson M.J. Localization of alpha 7 integrins and dystrophin suggests potential for both lateral and longitudinal transmission of tension in large mammalian muscles. Cell Tissue Res 2002, 308:255-265.
25. Bian W., Liau B., Badie N., Bursac N. Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protocols 2009, 4:1522-1534.
26. Fedorov V.V., Lozinsky I.T., Sosunov E.A., Anyukhovsky E.P., Rosen M.R., Balke C.W., et al. Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm 2007, 4:619-626.
27. Mayer U. Integrins: redundant or important players in skeletal muscle?. J Biol Chem 2003, 278:14587-14590.
28. King A.M., Loiselle D.S., Kohl P. Force generation for locomotion of vertebrates: skeletal muscle overview. Ieee J Oceanic Eng 2004, 29:684-691.
29. Vukicevic S., Kleinman H.K., Luyten F.P., Roberts A.B., Roche N.S., Reddi A.H. Identification of multiple active growth-factors in Basement-membrane matrigel suggests Caution in Interpretation of cellular-Activity related to extracellular-matrix components. Exp Cell Res 1992, 202:1-8.
30. Khodabukus A., Baar K. Regulating fibrinolysis to engineer skeletal muscle from the C2C12 cell line. Tissue Eng Part C Methods 2009, 15:501-511.
31. Mayer U., Saher G., Fassler R., Bornemann A., Echtermeyer F., von der Mark H., et al. Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nat Genet 1997, 17:318-323.
32. Rooney J.E., Gurpur P.B., Burkin D.J. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 2009, 106:7991-7996.
33. Katagiri Y., Hiroyama T., Akamatsu N., Suzuki H., Yamazaki H., Tanoue K. Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction. J Biol Chem 1995, 270:1785-1790.
34. Klein C.E., Dressel D., Steinmayer T., Mauch C., Eckes B., Krieg T., et al. Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol 1991, 115:1427-1436.
35. Menko A.S., Boettiger D. Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation. Cell 1987, 51:51-57.
36. Yao C.C., Ziober B.L., Sutherland A.E., Mendrick D.L., Kramer R.H. Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. J Cell Sci 1996, 109(Pt 13):3139-3150.
37. Wilschut K.J., Haagsman H.P., Roelen B.A. Extracellular matrix components direct porcine muscle stem cell behavior. Exp Cell Res 2010, 316:341-352.
38. Carson J.A., Wei L. Integrin signaling's potential for mediating gene expression in hypertrophying skeletal muscle. J Appl Physiol 2000, 88:337-343.
39. Kwon M.S., Park C.S., Choi K., Ahnn J., Kim J.I., Eom S.H., et al. Calreticulin couples calcium release and calcium influx in integrin-mediated calcium signaling. Mol Biol Cell 2000, 11:1433-1443.
40. Powell C., Shansky J., Del Tatto M., Vandenburgh H.H. Bioartificial muscles in gene therapy. Methods Mol Med 2002, 69:219-231.
41. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 2002, 90:223-230.
42. Siegal G.P., Wang M.H., Rinehart C.A., Kennedy J.W., Goodly L.J., Miller Y., et al. Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells. Cancer Lett 1993, 69:123-132.
43. Clark R.A., Nielsen L.D., Welch M.P., McPherson J.M. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta. J Cell Sci 1995, 108(Pt 3):1251-1261.
44. Long J.L., Tranquillo R.T. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 2003, 22:339-350.
45. Schense J.C., Bloch J., Aebischer P., Hubbell J.A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat Biotechnol 2000, 18:415-419.
46. Orban J.M., Wilson L.B., Kofroth J.A., El-Kurdi M.S., Maul T.M., Vorp D.A. Crosslinking of collagen gels by transglutaminase. J Biomed Mater Res A 2004, 68:756-762.
47. Lorentz K.M., Kontos S., Frey P., Hubbell J.A. Engineered aprotinin for improved stability of fibrin biomaterials. Biomaterials 2011, 32:430-438.